How much revenue does Unichem Laboratories make?

Unichem Laboratories reported 21.11 billion INR in revenue for fiscal year 2025, up 18.3% from 17.85 billion INR in fiscal year 2024. In Q3 2026 revenue was 5.21 billion INR.

What companies are similar to Unichem Laboratories?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Novartis India Limited (NOVARTIND.BO), RPG Life Sciences Limited (RPGLIFE.NS), Gufic Biosciences Limited (GUFICBIO.NS), Syncom Formulations (India) Limited (SYNCOMF.NS).

Unichem Laboratories Limited (UNICHEMLAB.NS) Stock

About Unichem Laboratories Limited

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in Asia, Europe, Africa, CIS, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers activ...

At a glance

Unichem Laboratories reported revenue of 21.11 billion INR for fiscal year 2025, up 18.3% from fiscal year 2024, and net income of 1.38 billion INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 5.21 billion INR, down 2.2% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.